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A B S T R A C T
To clarify the potential of dopamine to alter airway tone in the presence of diﬀerent bronchoconstrictor stimuli,
changes in airway function following dopamine administrations were characterized when the bronchial tone was
elevated by stimulating the histaminic or cholinergic pathway. Airway resistance, tissue damping and tissue
elastance were measured in anesthetized mechanically ventilated rabbits under baseline conditions, during
steady-state bronchoconstriction induced by methacholine or histamine, and following intravenous dopamine (5
and 15 μg/kg/min). Bronchoconstriction induced by methacholine and histamine was signiﬁcantly ameliorated
by dopamine (14.8 ± 2.9% and 14.9 ± 2.9%; p < 0.05 for both), with no diﬀerence between the mode of
stimuli. Dopamine had no eﬀect on the tissue mechanics. These ﬁndings indicate that dopamine relaxes the
elevated airway smooth muscle tone without aﬀecting the lung periphery, and this eﬀect is independent of the
mode of constrictor stimuli. This proﬁle of dopamine suggests its ability to treat eﬀectively cholinergic and
histaminergic bronchoconstriction, besides its positive inotropic eﬀects on the myocardial contractility.
1. Introduction
Bronchoconstriction is a major adverse event occurring both during
general anesthesia and critical care (Habre et al., 2017; Hirshman and
Bergman, 1990; Holzman, 1994; Nunn, 1990). Involvement of the
cholinergic pathway by direct stimulation of the muscarinic receptors is
frequent in the perioperative period, particularly during tracheal in-
tubation (Gal, 1980) or mechanical stimulation of the airways, i.e.
bronchoscopy or bronchial suction. The muscarinic receptors can also
be activated following acetylcholine liberation via vagal stimulation,
such as manipulation of the upper airways. Another mechanism re-
sponsible for the respiratory complications is triggered by the hista-
minergic pathway. Most of the anesthetic drugs, such as thiopentone,
morphine and neuromuscular blocking agents are known to induce
histamine release into the circulation (Doenicke et al., 1995; Hirshman
et al., 1985; North et al., 1987). Furthermore, lung function dete-
riorations observed after allergic reactions or cardiopulmonary bypass
are also mediated primarily by endogenous histamine release.
Dopamine is frequently used as an inotropic drug to elevate cardiac
output. In addition to the beneﬁcial cardiac eﬀect of this drug, the few
previous studies addressing its ability to alter the airway tone reported
controversial results (Babik et al., 2003; Cabezas et al., 1999; Chen and
Shue, 1992; Michoud et al., 1984). Some papers reported a broncho-
constrictive eﬀect of dopamine (Chen and Shue, 1992), whereas others
demonstrated neutral airway eﬀects (Thomson and Patel, 1978) or re-
laxation of an elevated bronchial smooth muscle tone (Cabezas et al.,
2003). Dopamine was eﬀective in reversing cholinergic bronchocon-
striction, whereas it enhanced the histamine-induced bronchoconstric-
tion (Chen and Shue, 1992). Therefore, the diﬀerences in the activated
pathway to preconstrict the airways may have importance.
Therefore, we aimed at clarifying the eﬀects of dopamine on the
respiratory system by comparing its potential to alter the airway tone
via two major pathways (i.e. cholinergic and histaminergic) involved in
the perioperative adverse respiratory events.
2. Materials and methods
2.1. Ethics approval
This study was approved by the Experimental Ethics Committee of
the University of Szeged Szeged, Hungary, on the 7th of December 2012
(no. I-74-50/2012), and authorized by the National Food Chain Safety
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and Animal Health Directorate of Csongrád County, Hungary (no. XIV/
152/ 2013, Chairperson Cs. Farle) on the 9th January 2013. The pro-
cedures were performed according to the guidelines of the Scientiﬁc
Committee of Animal Experimentation of the Hungarian Academy of
Sciences (updated Law and Regulations on Animal Protection: 40/2013.
(II. 14.) Government of Hungary), following the EU Directive 2010/63/
EU on the protection of animals used for scientiﬁc purposes, and re-
ported in compliance with the ARRIVE guidelines.
2.2. Animal preparations
Experiments were performed in two groups of New Zealand White
rabbits (2.0–2.68 kg), with 9 rabbits in the dopamine-treated group and
7 rabbits in the control group.
Anesthesia was induced by an intramuscular injection of xylazine
(5mg/kg, CP-Xylazin 2%, Produlab Pharma, Raamsdonksveer, The
Netherlands) followed by an intravenous dose of sodium pentobarbital
(30mg/kg) through a cannula placed in the marginal ear vein which
was used for anesthesia throughout the whole protocol by regular IV
injections (5 mg/kg every 30min). A polyethylene cannula was inserted
in the trachea through a tracheostomy following the subcutaneous
administration of local anaesthetics (lidocaine, 2-4 mg/kg). The rabbits
were placed on a heating pad and the tracheal cannula was connected
to a small animal ventilator (Model 683, Harvard Apparatus, South
Natick, MA, USA), and mechanically ventilated with room air (3035
breaths/min, tidal volume 7ml/kg). The femoral vein was catheterized
with a 3lumen catheter for drug delivery, a femoral artery was cathe-
terized (PV2013L07, Pulsion Medical Systems, Munich, Germany) and
attached to a pressure transducer (PV8115, Pulsion Medical Systems,
Munich, Germany) for measurement of systemic blood pressure and
thermodilution measurements. A jugular vein was also catheterized and
used for transpulmonary thermodilution measurements.
Neuromuscular blockade was achieved by repeated IV administration of
pipecuronium (0.1mg/kg, every 30min, Arduan, Richter-Gedeon,
Budapest, Hungary). Expired carbon-dioxide (CO2) traces were mon-
itored by using a mainstream capnograph (Novametrix, Capnogard®,
Andover, MA, USA) connected between the tracheal cannula and the
Ypiece of the ventilator circuit. Body temperature was kept in the
39 ± 0.5 °C range by using the heating pad.
2.3. Measurement of respiratory mechanics
The measurements of the input impedance spectra of the respiratory
system (Zrs) were carried out by forced oscillations (Babik et al., 2017;
Fodor et al., 2014). Mechanical ventilation was ceased at end-expira-
tion for an 8-s long period and the tracheal cannula was connected to a
loudspeaker-in-box system to deliver the forced oscillatory signal. The
loudspeaker delivered a computer-generated small-amplitude (< ±1
cmH2O) pseudo-random signal in the interval 0.5–21 Hz through a
screen pneumotachograph (11mm ID), which was used to measure the
gas ﬂow (V') with a diﬀerential pressure transducer (model 33NA002D;
ICSensors, Milpitas, CA, USA). An identical pressure transducer was
used to measure the pressure at the airway opening with reference to
the atmosphere (Pao).
The Pao and V' signals were low-pass ﬁltered at 25 Hz and sampled
with an analogue–digital board of a microcomputer at a rate of 256 Hz.
Fast Fourier transformation with 4-s time windows and 95% over-
lapping was used to calculate the Zrs spectra (Zrs= Pao/V'). Three to
four Zrs spectra were recorded at each experimental step which were
ensemble-averaged for further analysis.
2.4. Estimation of airway and parenchymal parameters
The airway and parenchymal mechanical properties of the re-
spiratory system were separated by ﬁtting a model to the averaged Zrs
spectra by minimizing the diﬀerences between the measured and
modelled impedance values. The model consisted of an airway com-
partment containing airway resistance (Raw) and airway inertance
(Iaw), and a constant-phase tissue unit (Hantos et al., 1992) char-
acterized by tissue damping (G) and elastance (H):
Zrs=Raw+ jωIaw+ (G− jH)/ωα
where j is the imaginary unit, ω is the angular frequency (2πf), and α is
(2/π) arctan (H/G).
2.5. Hemodynamic monitoring
Systemic hemodynamic parameters including the systolic (Psys) and
diastolic (Pdias) arterial blood pressure and mean arterial pressure
(MAP) were monitored by a transpulmonary arterial thermodilution
system (PiCCO; Pulsion Medical System, Munich, Germany). The ap-
paratus consists of a 4 F arterial catheter inserted into the femoral ar-
tery and a central venous catheter placed in a jugular vein. The thermal
indicator bolus (3 ml of< 8 °C saline) was injected into the right atrium
via the central venous line and the monitor determined the cardiac
output (CO) from the thermodilution curve.
2.6. Experimental protocol
The timeline of the experimental protocol is illustrated in Fig. 1.
After the animals reached a steady-state condition 510min following
completion of surgical preparation, lung volume history was standar-
dized by two moderate hyperinﬂations (double tidal volume) by oc-
cluding the expiratory port of the ventilator. Baseline respiratory me-
chanical parameters were assessed by measuring a data set of 34
reproducible Zrs recordings along with CO measurement. Following the
establishment of the baseline values, the animals were randomly given
either methacholine (MCh, 5 μg/kg/min) or histamine (Hist, 10 μg/kg/
min) as a constrictor agonist by a continuous IV infusion. After estab-
lishing a stable level of bronchoconstriction determined by a steady-
state increase of Raw (within 5%, approximately 15min after its onset),
another Zrs data set was recorded with 1-min interval between the
individual measurements and CO was also registered. Dopamine was
then administered to the animals of the dopamine group (Group DA) by
means of a continuous IV infusion (5 μg/kg/min), while the adminis-
tration of constrictor agonist was sustained. After 5min, a next set of
Zrs spectra were recorded along with CO data. Both infusions were then
ceased, and following a 30-min recovery period, a second baseline was
established in a similar fashion. Rabbits were then administered the
other constrictor agonist by a continuous IV infusion and measurements
were carried out after stabilization of the bronchoconstriction. Dopa-
mine was administered again at 5 μg/kg/min and Zrs and CO mea-
surements were carried out after 5min. The dose of dopamine was ﬁ-
nally elevated to 15 μg/kg/min, followed by recording Zrs and CO data
after 5min. Systemic hemodynamic parameters were registered at each
Fig. 1. Scheme of the experimental protocol. DA: dopamine, CTRL: control,
PiCCO: cardiac output measurements, FOT: respiratory mechanical measure-
ments. Constrictor challenge: continuous infusion of either methacholine or his-
tamine.
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step. The same experimental protocol was carried out in the rabbits
included in the control group (Group CTRL), however instead of the
inotrope, only saline was administered.
2.7. Statistical analysis
The scatters in the parameters were expressed as SE values. The
Shapiro-Wilk test was used to test data for normality. Three-way re-
peated measures of analysis of variances (ANOVA) with the factors
experimental group (Group DA or Group CTRL), experimental step
(baseline, constrictor, constrictor and dopamine) and constrictor ago-
nist (Hist or MCh) was used to assess the eﬀects dopamine on the re-
spiratory mechanical and hemodynamic parameters. The Holm-Sidak
multiple comparison procedure was applied to compare the diﬀerent
conditions (for repeated measures) or agonist types (for independent
groups). Correlation analyses between the variables were performed by
using Spearman correlation tests. Sample size was estimated based on
the Raw values as the primary outcome variable with an expected 25%
diﬀerence in the lung responsiveness, a power of 0.8 and two-sided
alpha error of 0.05. The estimation resulted in a required sample size of
5 for each group, based on the MCh-induced changes in Raw in our
earlier study (Porra et al., 2016). The statistical tests were performed
within the R environment with the lme4 (Bates et al., 2015) and lsmeans
(Lenth, 2016) packages and SigmaPlot 13 (Version 13, Systat Software,
Inc. Chicago, IL, USA), with a signiﬁcance level of p < 0.05.
3. Results
Hemodynamic eﬀects of the constrictor challenges and the con-
comitant dopamine administrations are demonstrated in Fig. 2. There
was no evidence for a change in any circulatory parameters to Hist,
while MCh infusion signiﬁcantly decreased all blood pressure variables
(p < 0.001). During MCh infusion, the higher dose of dopamine infu-
sion elevated all blood pressure parameters (p < 0.05) and CO sig-
niﬁcantly (p=0.039) demonstrating its positive inotropic activity.
Respiratory mechanical responses to the constrictor agonists and to
the simultaneous infusions of dopamine are depicted in Fig. 3. MCh and
Hist both deteriorated the mechanical properties of the respiratory
system with signiﬁcant elevations in Raw (p < 0.001) and G
(p < 0.02) and signiﬁcant decreases in Iaw (p < 0.04). There was no
further change in any of the respiratory mechanical parameters in the
CTRL group, proving the stability of both constrictor-induced dete-
riorations. Conversely, dopamine decreased Raw in the presence of
both MCh (p < 0.03) and Hist (p < 0.05).
To further clarify the eﬀects of dopamine on the respiratory me-
chanics in the presence of MCh or Hist induced constriction, respiratory
Fig. 2. Hemodynamic changes to methacholine, histamine and dopamine infusions. Psys: systolic blood pressure, Pdias: diastolic blood pressure, MAP: mean arterial
pressure, CO: cardiac output, DA: dopamine, Hist: histamine, MCh: methacholine, CTRL: control, Constr: MCh or Hist infusion alone. *: p < 0.05 Hist vs MCh within
a condition, #: p < 0.05 vs. Constr within a group.
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mechanical changes were also expressed relative to the values obtained
when the constrictor agonist was applied alone (Fig. 4). In the CTRL
group, no respiratory mechanical responses were observed. However,
dopamine induced signiﬁcant decreases in Raw (p < 0.03) in the
presence of both bronchoconstrictor agonists with no signiﬁcant dif-
ference between Hist and MCh. There was no evidence for a statistically
signiﬁcant eﬀect of dopamine on the respiratory tissues.
4. Discussion
Respiratory mechanical changes to dopamine were assessed in the
present study in an in vivo animal model mimicking clinical scenarios
encountered in anesthesia and intensive care management, where the
bronchial tone may be elevated by histaminergic and cholinergic
pathways. Besides the well-established beneﬁcial cardiovascular eﬀects
of dopamine, our ﬁndings demonstrate the ability of dopamine to al-
leviate bronchoconstriction mediated by both cholinergic and hista-
minergic pathways. Conversely, dopamine had no eﬀect on the re-
spiratory tissue mechanics.
The current forced oscillatory airway and respiratory tissue para-
meters agree well with those obtained earlier in similar sized rabbits
(Babik et al., 2017; Bayat et al., 2009). They also show good qualitative
concordance with previous data if the diﬀerences in methodology (i.e.
open vs closed chest) or body weight are taken into account (Doras
et al., 2015; Habre et al., 2002). Furthermore, the pattern and magni-
tude of the responses in the respiratory mechanical parameters to Hist
and MCh are also in accordance with previous results obtained under
similar experimental conditions (Habre et al., 2002, 2006; Hantos et al.,
1995).
An important feature of our experimental protocol is the existence
of a steady-state bronchoconstriction induced by Hist and MCh. In
agreement with previous results (Habre et al., 2001), stability of
bronchospasm in response to MCh can be achieved by sustained infu-
sions. While in case of Hist, a gradually decreasing response can be
anticipated due to tachyphylaxis, this phenomenon is more prominent
in the beginning of the challenge (Lutchen et al., 1994). Indeed, the 15-
min stabilization period was suﬃcient to obtain steady-state broncho-
constriction as proved by the lack of changes in Group CTRL (Fig. 3).
Regarding the cardiovascular responses of dopamine, it reversed
fully detrimental cardiovascular changes when the constrictor agonist
induced signiﬁcant losses of blood pressure and cardiac output (e.g.
MCh). This eﬀect is in accordance with the positive inotropic properties
of dopamine. In case of Hist, the doses required to induce similar
bronchial responses to MCh did not compromise the cardiovascular
system. Thus, in the presence of a normal cardiac function, dopamine
did not cause further improvements in agreement with previous data
obtained in rabbits at identical doses (Gosliga and Barter, 2015).
No diﬀerences were detected in the pattern and magnitude of the
respiratory mechanical eﬀects of MCh and Hist: both agents induced
constriction of the central conducting airways indicated by the eleva-
tions in Raw. In the single-compartment model Iaw is known to reﬂect
the mass of the gas in the airways and G reﬂects lung tissue damping.
Fig. 3. Respiratory mechanical responses to methacholine, histamine and dopamine infusions. Raw: airway resistance, Iaw: airway inertance, G: respiratory tissue
damping, H: respiratory tissue elastance. DA: dopamine, Hist: histamine, MCh: methacholine, CTRL: control, Constr: MCh or Hist infusion alone. *: p < 0.05 vs.
Constr within a group, #: p < 0.05 vs. Group CTRL with the same constrictor agonist.
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However, in case of development of peripheral ventilation hetero-
geneities, decreases in Iaw associated with elevations in G occur (Doras
et al., 2018; Lutchen et al., 1996; Petak et al., 1997). Under these cir-
cumstances dopamine infusions lowered airway resistance, indicating
the potential of this inotrope to relax central airway smooth muscle.
The lack of dopamine-induced changes in G and Iaw suggest that the
peripheral heterogeneities caused by MCh or Hist were not alleviated.
The most remarkable ﬁnding of the present study is the lack of
diﬀerences between the pattern and the magnitude of the bronchodi-
lator eﬀects of dopamine in the presence of MCh or Hist. In accordance
with this ﬁnding, there was a statistically signiﬁcant correlation be-
tween relative magnitude of the bronchodilator responses to dopamine
in the presence of MCh and Hist (r= 0.64, p=0.038, data not shown).
The existence of this relationship indicates that greater improvements
to dopamine in the presence of one agonist are also associated with
proportionally greater changes to the same dose of dopamine in the
presence of the other. These results demonstrate that the beneﬁcial
bronchial eﬀect of dopamine is mediated by means of pathways other
than direct histaminergic or cholinergic antagonism. Considering pre-
vious data, the bronchodilation eﬀects of dopamine may be mediated
by stimulation of bronchial β2 adrenergic receptors (Cortijo et al.,
1984) or dopamine receptors subtypes D1 or D2 (Cabezas and Velasco,
2010; Mizuta et al., 2012, 2013). Since bronchi have no sympathetic
innervation (van der Velden and Hulsmann, 1999), the involvement of
a neurally-mediated action of DA is unlikely, direct stimulation of do-
pamine and/or adrenergic receptors is more probable. However, the
exact identiﬁcation of the individual roles of these mechanisms may be
subject of further studies.
A limitation of the present study might be related to the route of
application of dopamine. While we applied dopamine intravenously,
previous studies evidenced bronchodilation in asthmatic patients un-
dergoing acute asthma attack when inhaled dopamine was applied
(Cabezas et al., 2003). Previous studies also described a diﬀerent pat-
tern of the eﬀect of MCh depending on the administration route (Petak
et al., 1997; Strengell et al., 2013). While the pattern of bronchocon-
striction was more homogeneous in case of the intravenous route as
evidenced by high resolution imaging, the summarized changes were
comparable between intravenous and inhalation route with no sig-
niﬁcant diﬀerences in total respiratory resistance and elastance
(Strengell et al., 2013). The same principle may be applied to dopa-
mine, i.e. the two routes likely exerting comparable respiratory eﬀects
with some diﬀerences in the heterogeneity and systemic haemody-
namics.
In summary, airway and respiratory tissue mechanical changes were
characterized following administrations of dopamine at 2 diﬀerent
doses against two constrictor stimuli. Our ﬁndings revealed that in
addition to the well-established beneﬁcial cardiovascular eﬀects of
dopamine, this inotrope ameliorates both cholinergic and histaminergic
bronchoconstriction in a similar degree. Measurement of airway and
respiratory tissue mechanics in an in vivo model revealed that the re-
versal of bronchoconstriction by dopamine is dominant in the central
conducting airways, while the responses in the peripheral airway and
Fig. 4. Respiratory mechanical responses to dopamine infusions relative to those obtained with methacholine or histamine infusions alone. Raw: airway resistance,
Iaw: airway inertance, G: respiratory tissue damping, H: respiratory tissue elastance. DA: dopamine, Hist: histamine, MCh: methacholine, CTRL: control, Constr: MCh
or Hist. *: p < 0.05 Hist vs MCh within a condition.
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tissue compartments were less apparent. The concomitant presence of
the already established beneﬁcial cardiovascular eﬀects of dopamine
and its dose- and stimulus-independent bronchodilator activity may
have importance when the circulatory and respiratory systems are both
impaired, such as in patients with heart failure associated with bron-
chial hyperreactivity or in those with an elevated bronchial tone sub-
sequent to impaired circulatory function. Under these circumstances
both the improved cardiovascular and respiratory functions to dopa-
mine may be particularly beneﬁcial.
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